Cargando…
Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
BACKGROUND: The related factors affecting the adherence of ischemic cerebral stroke (ICS) patients to antiplatelet therapy have attracted much attention. METHODS: Patients with ICS (confirmed by CT or MRI) were enrolled from January 2020 to July 2021. The demographic data were retrospectively invest...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175999/ https://www.ncbi.nlm.nih.gov/pubmed/37062920 http://dx.doi.org/10.1002/brb3.2982 |
_version_ | 1785040339913932800 |
---|---|
author | Zhong, Jie Gao, Yuguang Huang, Deqing Hu, Yueqiang He, Qianchao Diao, Limei Hu, Yuying Chen, Wei |
author_facet | Zhong, Jie Gao, Yuguang Huang, Deqing Hu, Yueqiang He, Qianchao Diao, Limei Hu, Yuying Chen, Wei |
author_sort | Zhong, Jie |
collection | PubMed |
description | BACKGROUND: The related factors affecting the adherence of ischemic cerebral stroke (ICS) patients to antiplatelet therapy have attracted much attention. METHODS: Patients with ICS (confirmed by CT or MRI) were enrolled from January 2020 to July 2021. The demographic data were retrospectively investigated and analyzed. The adherence calculation was as follows: Adherence = number of tablets taken/number of tablets needed to be taken. Adherence < 100% was defined as nonadherence. Severe nonadherence is defined as adherence ≤ 75%. RESULTS: A total of 229 patients with ICS were enrolled. We found no significant difference in the proportion of patients with nonadherence, while the proportion of severe nonadherence in the aspirin group was significantly higher (p < .001). Multivariable analysis indicated that medical insurance (odds ratio [OR] = 0.071, p < .001) and regular exercise (OR = 0.438, p = .015) were independent factors associated with adherence. In addition, only medical insurance (OR = 5.475, p < .001) and aspirin treatment (OR = 0.228, p < .001) were independent risk factors associated with severe nonadherence. We therefore constructed a nomogram plot and a model as follows: Adherence risk score = 3 × medical insurance + regular exercise. Patients were divided into low‐risk and high‐risk groups for adherence based on the median model score. A total of 13.3% of patients in the low‐risk group were nonadherent patients compared with 53.4% in the high‐risk group (p < .001). Similarly, 8.4% of patients in the low‐risk group had severe nonadherence compared with 19.9% in the high‐risk group (p = .022). Moreover, in low‐risk patients, no significant difference was observed. In patients with high risk, aspirin‐treated patients showed significantly decreased adherence compared with the other two groups. CONCLUSION: Medical insurance and regular exercise were independent factors for antiplatelet therapy adherence. For patients with high model scores, timely intervention is necessary. |
format | Online Article Text |
id | pubmed-10175999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101759992023-05-13 Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke Zhong, Jie Gao, Yuguang Huang, Deqing Hu, Yueqiang He, Qianchao Diao, Limei Hu, Yuying Chen, Wei Brain Behav Original Articles BACKGROUND: The related factors affecting the adherence of ischemic cerebral stroke (ICS) patients to antiplatelet therapy have attracted much attention. METHODS: Patients with ICS (confirmed by CT or MRI) were enrolled from January 2020 to July 2021. The demographic data were retrospectively investigated and analyzed. The adherence calculation was as follows: Adherence = number of tablets taken/number of tablets needed to be taken. Adherence < 100% was defined as nonadherence. Severe nonadherence is defined as adherence ≤ 75%. RESULTS: A total of 229 patients with ICS were enrolled. We found no significant difference in the proportion of patients with nonadherence, while the proportion of severe nonadherence in the aspirin group was significantly higher (p < .001). Multivariable analysis indicated that medical insurance (odds ratio [OR] = 0.071, p < .001) and regular exercise (OR = 0.438, p = .015) were independent factors associated with adherence. In addition, only medical insurance (OR = 5.475, p < .001) and aspirin treatment (OR = 0.228, p < .001) were independent risk factors associated with severe nonadherence. We therefore constructed a nomogram plot and a model as follows: Adherence risk score = 3 × medical insurance + regular exercise. Patients were divided into low‐risk and high‐risk groups for adherence based on the median model score. A total of 13.3% of patients in the low‐risk group were nonadherent patients compared with 53.4% in the high‐risk group (p < .001). Similarly, 8.4% of patients in the low‐risk group had severe nonadherence compared with 19.9% in the high‐risk group (p = .022). Moreover, in low‐risk patients, no significant difference was observed. In patients with high risk, aspirin‐treated patients showed significantly decreased adherence compared with the other two groups. CONCLUSION: Medical insurance and regular exercise were independent factors for antiplatelet therapy adherence. For patients with high model scores, timely intervention is necessary. John Wiley and Sons Inc. 2023-04-16 /pmc/articles/PMC10175999/ /pubmed/37062920 http://dx.doi.org/10.1002/brb3.2982 Text en © 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Zhong, Jie Gao, Yuguang Huang, Deqing Hu, Yueqiang He, Qianchao Diao, Limei Hu, Yuying Chen, Wei Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke |
title | Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke |
title_full | Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke |
title_fullStr | Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke |
title_full_unstemmed | Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke |
title_short | Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke |
title_sort | analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175999/ https://www.ncbi.nlm.nih.gov/pubmed/37062920 http://dx.doi.org/10.1002/brb3.2982 |
work_keys_str_mv | AT zhongjie analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke AT gaoyuguang analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke AT huangdeqing analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke AT huyueqiang analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke AT heqianchao analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke AT diaolimei analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke AT huyuying analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke AT chenwei analysisofantiplatelettherapyadherenceinpatientswithischemiccerebralstroke |